Table 1. Number of isolates by country and drug resistance profile.
| Country of sample origin | Time period of isolation | Enriched for resistance | Susceptible to all 4 drugs | Susceptible to 3 drugs, with missing pyrazinamide result | Isoniazid resistant, rifampicin susceptible | Isoniazid susceptible, rifampicin resistant | Isoniazid resistant, rifampicin resistant | Other pattern | Total |
|---|---|---|---|---|---|---|---|---|---|
| Australia | 2006-2016 | Yes | 0 | 0 | 4 | 0 | 38 | 0 | 42 |
| Belgium | 2007-2015 | Yes | 121 | 0 | 2 | 0 | 97 | 14 | 234 |
| Canada | 2003-2014 | Yes | 11 | 1,118 | 164 | 14 | 24 | 12 | 1343 |
| China | 2009-2012 | Yes | 0 | 44 | 0 | 0 | 236 | 0 | 280 |
| Germany | 1998-2015 | No | 248 | 0 | 9 | 1 | 13 | 2 | 273 |
| Italy | 2008-2016 | Yes and No* | 82 | 1 | 9 | 0 | 132 | 2 | 226 |
| Netherlands | 1993-2016 | No | 420 | 42 | 24 | 1 | 149 | 31 | 667 |
| Pakistan | 2014-2015 | Yes | 47 | 5 | 11 | 6 | 345 | 1 | 415 |
| Peru | 1997-2009 | Yes | 24 | 12 | 49 | 18 | 199 | 13 | 315 |
| Russia | 2008-2010 | Yes | 282 | 0 | 116 | 15 | 407 | 22 | 842 |
| Serbia | 2008-2014 | Yes | 0 | 0 | 0 | 0 | 105 | 0 | 105 |
| South Africa | 2012-2014 | Yes | 593 | 11 | 37 | 69 | 151 | 130 | 991 |
| Spain | 2013-2015 | Yes | 45 | 3 | 5 | 2 | 8 | 1 | 64 |
| Swaziland | 2009-2010 | Yes | 2 | 130 | 14 | 4 | 116 | 7 | 273 |
| Thailand | 1998-2013 | Yes | 0 | 53 | 7 | 4 | 188 | 0 | 252 |
| UK | 2009-2017 | Yes and No* | 3,036 | 82 | 167 | 6 | 442 | 154 | 3,887 |
| Total | 4911 | 1501 | 618 | 140 | 2650 | 389 | 10209 |
*
More than one collection was derived from Italy and the UK, some enriched and some not enriched for resistance. See supplement for details.